BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8356250)

  • 1. The need for aggressive therapy of rheumatoid arthritis.
    Wilske KR; Healey LA
    Rheum Dis Clin North Am; 1993 Feb; 19(1):153-61. PubMed ID: 8356250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Present and future therapeutic strategies in rheumatoid arthritis].
    Schacht E
    Z Rheumatol; 1993; 52(6):365-82. PubMed ID: 8147131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Winning the battle, losing the war? Another editorial about rheumatoid arthritis.
    Klippel JH
    J Rheumatol; 1990 Sep; 17(9):1118-22. PubMed ID: 2290151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to the management of rheumatoid arthritis: rationale for early combination therapy.
    Wilske KR
    Br J Rheumatol; 1993 Mar; 32 Suppl 1():24-7. PubMed ID: 8448633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of long-acting drugs in the treatment of rheumatoid arthritis.
    McDuffie FC
    J Med Assoc Ga; 1991 Sep; 80(9):487-93. PubMed ID: 1744528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early inflammatory arthritis versus rheumatoid arthritis.
    Finckh A
    Curr Opin Rheumatol; 2009 Mar; 21(2):118-23. PubMed ID: 19339921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New perspectives in the treatment of rheumatoid arthritis].
    Guzmán L
    Rev Med Chil; 1993 Jul; 121(7):789-90. PubMed ID: 8296084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early rheumatoid arthritis -- is there a window of opportunity?
    Cush JJ
    J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to control disease in rheumatoid arthritis with tumor necrosis factor antagonists-an opportunity to improve outcomes.
    Keystone EC
    Nat Clin Pract Rheumatol; 2006 Nov; 2(11):594-601. PubMed ID: 17075598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The systematic study of drug therapy in rheumatoid arthritis.
    Johnson K
    J Rheumatol Suppl; 1990 Nov; 25():34-8. PubMed ID: 2273520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
    Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
    Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early rheumatoid arthritis: strategies for prevention and management.
    Combe B
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):27-42. PubMed ID: 17350542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of current strategies in the future treatment of rheumatoid arthritis.
    Weinblatt ME
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():19-23. PubMed ID: 10646485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
    Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of rheumatoid arthritis.
    Binder AI
    Br J Hosp Med; 1992 Jul 1-28; 48(2):106-14. PubMed ID: 1298223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monotherapy in rheumatoid arthritis.
    Emery P
    Br J Rheumatol; 1993 Mar; 32 Suppl 1():21-3. PubMed ID: 8448632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's new in rheumatoid arthritis? An evidenced based review.
    Ostor AJ; McColl GJ
    Aust Fam Physician; 2001 Apr; 30(4):314-20. PubMed ID: 11355216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined disease-modifying chemotherapy for intractable rheumatoid arthritis.
    Bitter T
    Clin Rheum Dis; 1984 Aug; 10(2):417-28. PubMed ID: 6391796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.